|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash and cash equivalents - cash and due from bank | |||||||||||||
| Available-for-sale debt securities (net of credit losses of $0 at June 30, 2026 and December 31, 2025, respectively, amortized cost of $65,612 and $68,943 at June 30, 2026 and December 31, 2025, respectively) | |||||||||||||
| Held-to-maturity debt securities (net of allowance for credit losses of $0 as of June 30, 2026 and December 31, 2025) | |||||||||||||
| Equity securities | |||||||||||||
| Loans, net of allowance for credit losses of $860 and $842 at June 30, 2026 and December 31, 2025 | |||||||||||||
| Premises and equipment, net of accumulated depreciation of $3,003_ and $2,941 at June 30, 2026 and December 31, 2025 | |||||||||||||
| Federal Home Loan Bank stock | |||||||||||||
| Interest receivable | |||||||||||||
| Cash surrender value of bank-owned life insurance | |||||||||||||
| Deferred income taxes | |||||||||||||
| Mortgage servicing rights | |||||||||||||
| Income tax receivable | |||||||||||||
| Other | |||||||||||||
| Total assets | |||||||||||||
| Liabilities and Equity Capital | |||||||||||||
| Liabilities | |||||||||||||
| Deposits | |||||||||||||
| Demand | |||||||||||||
| Savings, NOW and money market | |||||||||||||
| Time | |||||||||||||
| Total deposits | |||||||||||||
| Deferred compensation | |||||||||||||
| Income tax payable | |||||||||||||
| Interest payable and other liabilities | |||||||||||||
| Total liabilities | |||||||||||||
| Stockholders' Equity | |||||||||||||
| Common Stock, $0.01 par value, 14,000,000 shares authorized, 1,735,649 issued, 1,557,237 and 1,562,319 outstanding at June 30, 2026 and December 31, 2025 | |||||||||||||
| Additional Paid in Capital | |||||||||||||
| Unallocated common stock of ESOP | |||||||||||||
| Treasury stock - 178,412 shares at June 30, 2026 and 162,681 shares at December 31, 2025 | |||||||||||||
| Deferred compensation liability - 40,000 shares held in trust at June 30, 2026 and December 31, 2025 | |||||||||||||
| Retained earnings | |||||||||||||
| Accumulated other comprehensive (loss) | |||||||||||||
| Total stockholders' equity | |||||||||||||
| Total liabilities and stockholders' equity |
Loading...
